Blavatnik Biomedical Accelerator at Harvard University
Therapeutic Approaches: Biologics, Small Molecules, Vaccines, Biomarkers, Antibodies, Stem Cells, Gene Therapy, Drug Delivery, Drug Devices, Diagnostic and analytical methods, biomaterials
Therapeutic Areas of Expertise: Cardiology, Gene-Therapy, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Ophthalmology, Psychiatric Disorders, Pain, Regenerative Medicine
Center/Program Highlights:
Biomedical research at Harvard has the potential to improve countless lives, revolutionize industries, and create immense social and economic value. Translating this early-stage research into compelling, validated technologies requires careful planning, focused resources, and a tireless pursuit of results.
The Accelerator seeks to support innovative, investigator-initiated research, and to develop preliminary observations into robust intellectual property positions. Its primary goal is to advance technologies to the point where an industry partnership can commence.
We employ a proven strategy of selecting projects with significant commercial potential, and providing financial support and domain expertise to fuel translational research, proof-of-concept, and technological development. We simultaneously build relationships with industry, generating partnerships and licensing opportunities, and facilitating startup formation and investment.
Sources of Funding: Philanthropy, Revenue
Institutional Affiliation(s): Harvard University
Address:
Smith 639, 1350 Massachusetts Avenue
Cambridge
Massachusetts, 02138
United States
Center/Program Start Date: 2007
Number of Employees: 3
